| Identification | Back Directory | [Name]
TP 235 | [CAS]
443104-02-7 | [Synonyms]
TP 235
CPD1598
CDDO-IM
RTA 403
CDDO IMidazolide
CDDO-Im (RTA-403)
CDDO-Im, RTA 403, TP 235
2-Cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid iMidazolide
1-(2-Cyano-3,12,28-trioxooleana-1,9(11)-dien-28-yl)-1H-iMidazole
1H-Imidazole, 1-(2-cyano-3,12,28-trioxooleana-1,9(11)-dien-28-yl)-
(4aR,6aR,6aS,6bR,8aS,12aS,14bS)-8a-(imidazole-1-carbonyl)-4,4,6a,6b,11,11,14b-heptamethyl-3,13-dioxo-4a,5,6,6a,7,8,9,10,12,12a-decahydropicene-2-carbonitrile | [Molecular Formula]
C34H43N3O3 | [MDL Number]
MFCD12756341 | [MOL File]
443104-02-7.mol | [Molecular Weight]
541.72 |
| Chemical Properties | Back Directory | [Melting point ]
>164°C (dec.) | [Boiling point ]
681.8±65.0 °C(Predicted) | [density ]
1.23±0.1 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,2-8°C | [solubility ]
Chloroform (Slightly), Methanol (Very Slightly, Heated) | [form ]
Solid | [pka]
3.47±0.10(Predicted) | [color ]
Pale Yellow to Very Dark Yellow | [Stability:]
Light Sensitive |
| Hazard Information | Back Directory | [Chemical Properties]
Pale Yellow Solid | [Uses]
CDDO Imidozolide (CDDO-Im) is a synthetic triterpenoid CDDO-Im inhibits fatty acid synthase expression and has antiproliferative and proapoptotic effects in human liposarcoma cells. Studies show that
CDDO-Im is highly active in suppressing cellular proliferation of human leukemia and breast cancer cell lines as well as being an effective therapeutic agent in the treatment of other types of cancers
. | [storage]
Store at RT |
|
| Company Name: |
SPIRO PHARMA
|
| Tel: |
|
| Website: |
www.spiropharma.com.cn |
|